KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Globus Medical (GMED) Equity Average (2016 - 2025)

Historic Equity Average for Globus Medical (GMED) over the last 14 years, with Q3 2025 value amounting to $4.3 billion.

  • Globus Medical's Equity Average rose 806.32% to $4.3 billion in Q3 2025 from the same period last year, while for Sep 2025 it was $4.3 billion, marking a year-over-year increase of 806.32%. This contributed to the annual value of $4.1 billion for FY2024, which is 3988.41% up from last year.
  • According to the latest figures from Q3 2025, Globus Medical's Equity Average is $4.3 billion, which was up 806.32% from $4.2 billion recorded in Q2 2025.
  • Over the past 5 years, Globus Medical's Equity Average peaked at $4.3 billion during Q3 2025, and registered a low of $1.5 billion during Q1 2021.
  • Its 5-year average for Equity Average is $2.8 billion, with a median of $1.9 billion in 2023.
  • Its Equity Average has fluctuated over the past 5 years, first soared by 12670.77% in 2023, then skyrocketed by 75.12% in 2024.
  • Over the past 5 years, Globus Medical's Equity Average (Quarter) stood at $1.7 billion in 2021, then rose by 4.36% to $1.8 billion in 2022, then skyrocketed by 126.71% to $4.1 billion in 2023, then increased by 0.75% to $4.1 billion in 2024, then grew by 5.43% to $4.3 billion in 2025.
  • Its last three reported values are $4.3 billion in Q3 2025, $4.2 billion for Q2 2025, and $4.1 billion during Q1 2025.